A5067324486- Neurofibromatosis and Schwannoma Cases
- Soft tissue tumor case studies
- Soft tissue tumors and treatment
- COVID-19 and healthcare impacts
- Cardiovascular Disease and Adiposity
- Cardiac Valve Diseases and Treatments
- Cardiovascular Health and Risk Factors
- Cardiac Arrhythmias and Treatments
- Healthcare Regulation
- Balance, Gait, and Falls Prevention
- Ultrasound and Hyperthermia Applications
- Cardiac Health and Mental Health
- Telemedicine and Telehealth Implementation
- Rheumatoid Arthritis Research and Therapies
- Atrial Fibrillation Management and Outcomes
- Ultrasound in Clinical Applications
- Foot and Ankle Surgery
- Cardiac Imaging and Diagnostics
- Infective Endocarditis Diagnosis and Management
- Psoriasis: Treatment and Pathogenesis
- Cardiomyopathy and Myosin Studies
- Stroke Rehabilitation and Recovery
- Cardiovascular Health and Disease Prevention
The University of Sydney
2021-2024
Royal North Shore Hospital
2023-2024
Liverpool Hospital
2022
Royal Adelaide Hospital
2021
Baird Institute
2021
Stress echocardiography (SE) is one of the most commonly used diagnostic imaging tests for coronary artery disease (CAD) but requires clinicians to visually assess scans identify patients who may benefit from invasive investigation and treatment. EchoGo Pro provides an automated interpretation SE based on artificial intelligence (AI) image analysis. In reader studies, use when making clinical decisions improves accuracy confidence. Prospective evaluation in real world practice now important...
IMPORTANCE: The evidence that maintaining a healthy body weight in conjunction with healthier eating patterns, exercise training, and reduced stress can improve clinical outcomes patients atherosclerotic cardiovascular disease is substantial. However, little known about the magnitude temporal effects of comprehensive lifestyle treatment on coronary artery anatomy, myocardial inflammation, fibrosis people affected by heart disease. OBJECTIVE: To conduct randomised trial to determine impact...
Abstract Background Cutaneous neurofibromas (cNFs) are a major cause of disfigurement in patients with Neurofibromatosis Type 1 (NF1). However, clinical trials investigating cNF treatments lack standardised outcome measures to objectively evaluate changes size and appearance. 3D imaging has been proposed as an objective measure however various systems exist different features that affect useability settings. The aim this study was compare the accuracy, precision, feasibility, reliability...